Correlates of protection against COVID-19 infection and intensity of symptomatic disease in vaccinated individuals exposed to SARS-CoV-2 in households in Israel …

G Regev-Yochay, Y Lustig, G Joseph, M Gilboa… - The Lancet …, 2023 - thelancet.com
Background Identifying COVID-19 correlates of protection and immunity thresholds is
important for policy makers and vaccine development. We aimed to identify correlates of …

Durable CD8 T cell memory against SARS-CoV-2 by Prime/Boost and multi-dose vaccination: Considerations on inter-dose time intervals

A Natalini, S Simonetti, C Sher, U D'Oro… - International Journal of …, 2022 - mdpi.com
Facing the COVID-19 pandemic, anti-SARS-CoV-2 vaccines were developed at
unprecedented pace, productively exploiting contemporary fundamental research and prior …

Use of Hu-PBL mice to study pathogenesis of human-restricted viruses

JE Brunetti, M Kitsera, C Muñoz-Fontela, E Rodríguez - Viruses, 2023 - mdpi.com
Different humanized mouse models have been developed to study human diseases such as
autoimmune illnesses, cancer and viral infections. These models are based on the use of …

Immune and behavioral correlates of protection against symptomatic post-vaccination SARS-CoV-2 infection

E Goguet, CH Olsen, WA Meyer III, S Ansari… - Frontiers in …, 2024 - frontiersin.org
Introduction We sought to determine pre-infection correlates of protection against SARS-
CoV-2 post-vaccine inzfections (PVI) acquired during the first Omicron wave in the United …

Rebound in asthma exacerbations following relaxation of COVID-19 restrictions: a longitudinal population-based study (COVIDENCE UK)

F Tydeman, PE Pfeffer, G Vivaldi, H Holt, M Talaei… - thorax, 2023 - thorax.bmj.com
Background The imposition of restrictions on social mixing early in the COVID-19 pandemic
was followed by a reduction in asthma exacerbations in multiple settings internationally …

Influence of individuals' determinants including vaccine type on cellular and humoral responses to SARS-CoV-2 vaccination

ES Chambers, W Cai, G Vivaldi, DA Jolliffe, N Perdek… - npj Vaccines, 2024 - nature.com
Vaccine development targeting SARS-CoV-2 in 2020 was of critical importance in reducing
COVID-19 severity and mortality. In the UK during the initial roll-out most individuals either …

Assessing vulnerability to COVID-19 in high-risk populations: the role of SARS-CoV-2 spike-targeted serology

HW Kaufman, WA Meyer, NJ Clarke… - Population Health …, 2023 - liebertpub.com
Individuals at increased risk for severe coronavirus disease-2019 (COVID-19) outcomes,
due to compromised immunity or other risk factors, would benefit from objective measures of …

[HTML][HTML] Impact of the COVID-19 vaccine booster strategy on vaccine protection: a pilot study of a military hospital in Taiwan

YL Wang, ST Cheng, CF Shen, SW Huang… - Clinical and …, 2023 - ncbi.nlm.nih.gov
Purpose The global fight against the severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) pandemic has led to widespread vaccination efforts, yet the optimal dosing …

Long-term air pollution exposure and risk of SARS-CoV-2 infection: A UK-wide cohort study

H Hajmohammadi, M Talaei, D Fecht, W Wang… - Respiratory …, 2024 - Elsevier
Background The association between air quality and risk of SARS-CoV-2 infection is poorly
understood. We investigated this association using serological individual-level data …

[HTML][HTML] Humoral and Innate Immunological Profile of Paediatric Recipients of Pfizer-BioNTech BNT162b2 mRNA Vaccine

SS Jeremiah, P Das, M Venkatesan, R Albinzayed… - Microorganisms, 2024 - mdpi.com
The Pfizer-BioNTech vaccine was one of the essential tools in curtailing the COVID-19
pandemic. Unlike conventional vaccines, this newly approved mRNA vaccine is taken up by …